Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 18:8:474.
doi: 10.3389/fphar.2017.00474. eCollection 2017.

Metabolomics and Integrative Omics for the Development of Thai Traditional Medicine

Affiliations
Review

Metabolomics and Integrative Omics for the Development of Thai Traditional Medicine

Sakda Khoomrung et al. Front Pharmacol. .

Abstract

In recent years, interest in studies of traditional medicine in Asian and African countries has gradually increased due to its potential to complement modern medicine. In this review, we provide an overview of Thai traditional medicine (TTM) current development, and ongoing research activities of TTM related to metabolomics. This review will also focus on three important elements of systems biology analysis of TTM including analytical techniques, statistical approaches and bioinformatics tools for handling and analyzing untargeted metabolomics data. The main objective of this data analysis is to gain a comprehensive understanding of the system wide effects that TTM has on individuals. Furthermore, potential applications of metabolomics and systems medicine in TTM will also be discussed.

Keywords: Thai traditional medicine; analytical chemistry; herbal medicines; integrative omics; metabolomics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of the steps involved in untargeted metabolomics.
Figure 2
Figure 2
Overview of the steps involved in targeted metabolomics.
Figure 3
Figure 3
Integration of multi-omics and clinical data into TTM. (A) Herbal plants and herbal medicines. (B) Chemical characterization of herbal plants, herbal medicines, and biofluids using targeted and untargeted metabolomics. (C) Clinical trial of herbal plants and herbal medicines by cell lines, animal, or human models. (D) Biofluid for metabolome analysis. (E) Integrative analysis of different omics data and clinical data. (F) Systems biology network. (G) Individualized data.

References

    1. Akarasereenont P., Datiles M. J. R., Lumlerdkij N., Yaakob H., Prieto J. M. M., Heinrich M. (2015). A south-east asian perspective on ethnopharmacology, in Ethnopharmacology, eds Heinrich M., Jäger A. K. (Chennai: John Wiley & Sons Ltd; ), 317–329.
    1. Andreu-Perez J., Poon C. C. Y., Merrifield R. D., Wong S. T. C., Yang G. Z. (2015). Big data for health. IEEE J. Biomed. Health Inform. 19, 1193–1208. 10.1109/JBHI.2015.2450362 - DOI - PubMed
    1. Armitage E. G., Barbas C. (2014). Metabolomics in cancer biomarker discovery: current trends and future perspectives. J. Pharm. Biomed. Anal. 87, 1–11. 10.1016/j.jpba.2013.08.041 - DOI - PubMed
    1. Barri T., Dragsted L. O. (2013). UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal. Chim. Acta 768, 118–128. 10.1016/j.aca.2013.01.015 - DOI - PubMed
    1. Bartel J., Krumsiek J., Schramm K., Adamski J., Gieger C., Herder C., et al. (2015). The human blood metabolome-transcriptome interface. PLoS Genet. 11:e1005274. 10.1371/journal.pgen.1005274 - DOI - PMC - PubMed

LinkOut - more resources